CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CANbridge Pharmaceuticals Inc. has announced the resignation of Dr. Kan Chen as a non-executive Director and member of the audit committee, effective September 2, 2024. Dr. Chen’s departure is due to a desire to focus on personal commitments, with no reported disagreements or contentious issues related to his resignation. In his stead, Dr. Richard James Gregory will join the audit committee, as the company expresses gratitude to Dr. Chen for his service.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.